Study of Latiglutenase in T1D/CD Patients
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial studies people with both Type 1 diabetes and celiac disease who have been on a gluten-free diet for a significant period. The goal is to see if avoiding gluten helps manage both conditions better. By not eating gluten, these patients can prevent their immune system from damaging their intestines, which might also help control their diabetes.
Do I need to stop my current medications for the trial?
The trial information does not specify if you need to stop taking your current medications. It's best to discuss this with the trial coordinators.
Who Is on the Research Team?
David Maahs, MD
Principal Investigator
Stanford University
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either Latiglutenase or placebo in a double-blind, crossover design
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Latiglutenase
Find a Clinic Near You
Who Is Running the Clinical Trial?
Entero Therapeutics
Lead Sponsor
Immunogenics, LLC
Industry Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator